|
tweede vaccinatie tegen 'severe acute respiratory syndrome'-coronavirus 2 met 'messenger'-ribonucleïnezuurvaccin (verrichting)
tweede vaccinatie tegen SARS-CoV-2 met mRNA-vaccin
tweede toediening van mRNA-vaccin tegen COVID-19
tweede vaccinatie tegen 'severe acute respiratory syndrome'-coronavirus 2 met 'messenger'-ribonucleïnezuurvaccin
tweede actieve immunisatie met SARS-CoV-2-mRNA-vaccin
Administration of second dose of SARS-CoV-2 mRNA vaccine
Second COVID-19 mRNA vaccination
Second SARS-CoV-2 mRNA immunization
Second 2019 novel coronavirus mRNA vaccination
Second 2019 novel coronavirus mRNA immunization
Second 2019-nCoV mRNA vaccination
Second SARS-CoV-2 mRNA vaccination
Second 2019-nCoV mRNA immunization
Second severe acute respiratory syndrome coronavirus 2 mRNA vaccination
Second COVID-19 mRNA immunization
Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid
Id1144998002
StatusPrimitive
Global Patient Set